David A. Pierce's Insider Trades & SAST Disclosures
David A. Pierce's most recent trade in Diversified Healthcare Trust was a trade of 20,000 Common Shares of Beneficial Interest done . Disclosure was reported to the exchange on June 5, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David A. Pierce.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Diversified Healthcare Trust | David A. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 20,000 | 40,000 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 2,444 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.94 per share. | 28 Feb 2022 | 1,726 | 0 (0%) | 0% | 43.9 | 75,840 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.17 per share. | 28 Feb 2022 | 718 | 1,726 (0%) | 0% | 44.2 | 31,714 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 17,439 | 17,439 | - | - | Performance Share Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 22 Feb 2022 | 1,884 | 1,761 (0%) | 0% | 42.5 | 80,164 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.28 per share. | 22 Feb 2022 | 1,761 | 0 (0%) | 0% | 43.3 | 76,216 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,493 | 4,377 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,493 | 2,493 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 21 Feb 2022 | 732 | 3,645 (0%) | 0% | 42.6 | 31,147 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 3,333 | 3,333 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 3,333 | 10,000 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,668 | 5,337 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,668 | 5,022 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 42.88 per share. | 17 Feb 2022 | 2,354 | 1,884 (0%) | 0% | 42.9 | 100,940 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.83 per share. | 17 Feb 2022 | 979 | 2,354 (0%) | 0% | 42.8 | 41,931 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 17 Feb 2022 | 784 | 4,238 (0%) | 0% | 42.5 | 33,359 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 2,769 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 2,769 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.81 per share. | 15 Feb 2022 | 1,956 | 0 (0%) | 0% | 43.8 | 85,692 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.01 per share. | 15 Feb 2022 | 813 | 1,956 (0%) | 0% | 44.0 | 35,780 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.54 per share. | 04 Jan 2022 | 6,161 | 0 (0%) | 0% | 43.5 | 268,230 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 8,982 | 0 | - | - | Performance Share Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 8,982 | 8,982 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.48 per share. | 01 Jan 2022 | 2,821 | 6,161 (0%) | 0% | 42.5 | 119,836 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.90 per share. | 20 Dec 2021 | 49,988 | 0 (0%) | 0% | 39.9 | 1,994,621 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.39 per share. | 20 Dec 2021 | 42,934 | 44,991 (0%) | 0% | 7.4 | 317,282 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 42,934 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 4,997 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 20 Dec 2021 | 4,997 | 49,988 (0%) | 0% | 6.3 | 31,381 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 41.36 per share. | 03 Jun 2021 | 1,654 | 2,057 (0%) | 0% | 41.4 | 68,409 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 2,973 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 2,973 | 5,030 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Jun 2021 | 1,319 | 3,711 (0%) | 0% | 42.9 | 56,625 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.36 per share. | 16 Mar 2021 | 7,603 | 2,057 (0%) | 0% | 39.4 | 299,246 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.90 per share. | 02 Mar 2021 | 1,360 | 9,660 (0%) | 0% | 38.9 | 52,904 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2021 | 2,444 | 12,104 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2021 | 2,444 | 2,444 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.78 per share. | 28 Feb 2021 | 1,084 | 11,020 (0%) | 0% | 38.8 | 42,038 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.20 per share. | 23 Feb 2021 | 2,836 | 9,660 (0%) | 0% | 39.2 | 111,171 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 9,456 | 9,456 | - | - | Performance Share Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,607 | 13,653 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,607 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,492 | 12,152 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,492 | 4,986 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 19 Feb 2021 | 1,484 | 9,660 (0%) | 0% | 38 | 56,392 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.20 per share. | 19 Feb 2021 | 1,157 | 12,496 (0%) | 0% | 39.2 | 45,354 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.03 per share. | 19 Feb 2021 | 1,106 | 11,046 (0%) | 0% | 38.0 | 42,061 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 42,881 | 42,881 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 13,333 | 13,333 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 2,668 | 8,005 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 2,668 | 12,328 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.52 per share. | 17 Feb 2021 | 1,184 | 11,144 (0%) | 0% | 37.5 | 44,424 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2021 | 2,768 | 5,538 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2021 | 2,768 | 12,428 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 15 Feb 2021 | 1,540 | 9,660 (0%) | 0% | 38.3 | 58,951 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.39 per share. | 15 Feb 2021 | 1,228 | 11,200 (0%) | 0% | 38.4 | 47,143 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 10,796 | 12,853 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.85 per share. | 10 Feb 2021 | 3,193 | 9,660 (0%) | 0% | 38.8 | 124,048 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 04 Feb 2021 | 11,317 | 2,057 (0%) | 0% | 38 | 430,046 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 16,318 | 0 | - | - | Performance Share Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 16,318 | 16,980 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.95 per share. | 01 Jan 2021 | 5,001 | 11,979 (0%) | 0% | 36.0 | 179,786 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 09 Nov 2020 | 2,028 | 662 (0%) | 0% | 39 | 79,092 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.56 per share. | 01 Oct 2020 | 2,282 | 2,690 (0%) | 0% | 38.6 | 87,994 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 40.70 per share. | 01 Sep 2020 | 2,044 | 4,972 (0%) | 0% | 40.7 | 83,191 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.69 per share. | 03 Aug 2020 | 2,385 | 7,016 (0%) | 0% | 38.7 | 92,276 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 22 Jul 2020 | 2,170 | 9,401 (0%) | 0% | 38 | 82,460 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 03 Jun 2020 | 1,624 | 11,571 (0%) | 0% | 38 | 61,712 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 2,972 | 2,973 | - | - | Deferred Stock Units | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 2,972 | 16,512 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 01 Jun 2020 | 1,969 | 13,195 (0%) | 0% | 38 | 74,822 | Common Stock |
| Boston Scientific Corp. | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.50 per share. | 01 Jun 2020 | 1,348 | 15,164 (0%) | 0% | 37.5 | 50,550 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges